Ob.Gyn. NewsDon’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance saysMarch 11, 2021OsteoporosisCOVID-19 Updates
Ob.Gyn. NewsCumulative exposure to high-potency topical steroid doses drives osteoporosis fracturesFebruary 16, 2021Osteoporosis
Ob.Gyn. NewsTemper enthusiasm for long-term treatment with bisphosphonates?December 26, 2020Osteoporosis
Ob.Gyn. NewsOral steroids plus PPIs increase osteoporotic fracture risk in RA patientsDecember 17, 2020Osteoporosis
Ob.Gyn. NewsDenosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosisNovember 9, 2020Osteoporosis
Ob.Gyn. NewsTreatment sequence with romosozumab influences osteoporosis outcomesNovember 9, 2020Osteoporosis
Ob.Gyn. NewsBiologics may protect psoriasis patients against severe COVID-19November 2, 2020COVID-19 UpdatesOsteoporosis
Ob.Gyn. NewsLonger bisphosphonate use ups AFF risk, but not all is tied to drugSeptember 22, 2020Osteoporosis
Ob.Gyn. NewsTreat-to-target strategy ‘not ready for primetime’ in osteoporosisSeptember 18, 2020Osteoporosis
Ob.Gyn. NewsCagA-positive H. pylori patients at higher risk of osteoporosis, fractureSeptember 1, 2020Osteoporosis
Ob.Gyn. NewsAtypical fractures with bisphosphonates highest in Asians, study confirmsAugust 20, 2020Osteoporosis
